Amanda Magnoli
Nurse Practitioner · Westbrook, MENPI 1689945420
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $80,188 of the $113,268 with a category attached, or 70.8%. 25 manufacturers reported payments, led by Daiichi Sankyo Inc. at 37.6% of the total. 2025 is the largest year on record at $49,804, more than ten times the $49 reported in 2021. Among nurse practitioner clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $521.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$43K
- AstraZeneca$39K
- Gilead$31K
- AbbVie$196
- Takeda Pharmaceuticals U.S.A., Inc.$169
- Incyte Corporation$128
- plus $897 from 19 others
What the payments were for
- Consulting fees$1,8352%
- Speaking & faculty fees$80,18871%
- Travel & lodging$24,90022%
- Food & beverage$6,1735%
- Education$1730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 50 | $42,549 |
| AstraZeneca | 44 | $38,741 |
| Gilead | 77 | $30,589 |
| AbbVie | 7 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $169 |
| Incyte Corporation | 5 | $128 |
| GSK | 1 | $118 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $104 |
| Tempus AI, Inc | 1 | $84 |
| Rigel Pharmaceuticals, Inc. | 1 | $84 |
| Sanofi | 3 | $72 |
| Johnson & Johnson | 2 | $72 |
| Amgen | 3 | $61 |
| Novocure Inc. | 1 | $41 |
| Blueprint Medicines Corporation | 1 | $40 |
| ADC Therapeutics America, Inc. | 2 | $35 |
| Novartis | 2 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Tolmar, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Stemline Therapeutics Inc. | 1 | $17 |
| Merck | 1 | $15 |
| Caris MPI, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$113,268 in reported general payments places this provider in the 95th percentile of 740 nurse practitioner providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VerzenioAbemaciclib | 28 | $428,685 |
| IbrancePalbociclib | 19 | $211,387 |
| Letrozole | 50 | $1,349 |
| Anastrozole | 36 | $540 |
| Tamoxifen Citrate | 18 | $434 |
| Ondansetron OdtOndansetron | 21 | $330 |
| Prochlorperazine Maleate | 24 | $220 |
| Lorazepam | 15 | $41 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Westbrook
- Jamie TheriaultWestbrook$1K
- Jennifer CaldwellWestbrook$784
- Gisele CastonguayLewiston$26K
- Rachel Koransky-MatsonBangor$16K
- Denise ViekmanPortland$15K
- Kerri NeelYork$5K
- Mallory EvansYork$5K
- Karrie SweetPortland$5K
- Noelle CooperSouth Portland$4K
- Kimberlee SmithKittery$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.